{
    "2019-10-18": [
        [
            {
                "time": "2018-11-15",
                "original_text": "New Gilead CFO: Let's Make a Deal",
                "features": {
                    "keywords": [
                        "Gilead",
                        "CFO",
                        "Deal"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-16",
                "original_text": "Pharma Stock Roundup: JNJ's Q3 Earnings, RHHBY's Sales, FDA Nod to Lilly's Reyvow",
                "features": {
                    "keywords": [
                        "Pharma",
                        "JNJ",
                        "Q3 Earnings",
                        "RHHBY",
                        "Sales",
                        "FDA",
                        "Lilly",
                        "Reyvow"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}